Titralac
Product Images NDC 55298-038

1 FDA label image from Inova Pharmaceuticals Pty, Ltd · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Titralac (NDC 55298-038). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Inova Pharmaceuticals Pty, Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel – Bottle Label (Tit00 0000 01)

Principal Display Panel – Bottle Label (Tit00 0000 01)
Drug Facts panels for Titralac Antacid tablets displaying active ingredient calcium carbonate 420 mg per tablet, purpose as antacid, uses for heartburn, sour stomach, and acid indigestion relief. Warnings advise consulting a doctor if taking prescription drugs or symptoms last more than two weeks. Directions include chewing or swallowing two tablets every two to three hours as needed, with limits on maximum dosage. Additional information notes sugar-free status, low sodium, low aluminum content, and inactive ingredients including glycine, magnesium stearate, saccharin, spearmint oil, and starch.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.